Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus

Skin Pruritus Clinical Trial

Official title: A Phase II, Single Center, Double-blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of PAC-14028 Cream in Dermal Pruritus

Status Completed

Clinical Trial Summary

The objective of this study was to find a clinically appropriate dose of PAC-14028 cream by comparatively evaluating the efficacy and safety of PAC-14028 cream of Amorepacific Corporation in patients with dermal pruritus.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Pruritus
• Skin Pruritus

• NCT number: NCT02052531
• Study type: Interventional
• Source: Amorepacific Corporation
• Status: Completed
• Phase: Phase 2
• Start date: January 2013
• Completion date: July 2013